Advertisement

Behavior Genetics

, Volume 47, Issue 5, pp 564–580 | Cite as

Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in “Impulsive” SHR/NCrl and Wistar Rats

  • Ike dela PeñaEmail author
  • Irene Joy dela Peña
  • June Bryan de la Peña
  • Hee Jin Kim
  • Chan Young Shin
  • Doug Hyun Han
  • Bung-Nyun Kim
  • Jong Hoon Ryu
  • Jae Hoon CheongEmail author
Original Research

Abstract

Impulsivity, the predisposition to act prematurely without foresight, is associated with a number of neuropsychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD). Identifying genetic underpinnings of impulsive behavior may help decipher the complex etiology and neurobiological factors of disorders marked by impulsivity. To identify potential genetic factors of impulsivity, we examined common differentially expressed genes (DEGs) in the prefrontal cortex (PFC) of adolescent SHR/NCrl and Wistar rats, which showed marked decrease in preference for the large but delayed reward, compared with WKY/NCrl rats, in the delay discounting task. Of these DEGs, we examined drug-responsive transcripts whose mRNA levels were altered following treatment (in SHR/NCrl and Wistar rats) with drugs that alleviate impulsivity, namely, the ADHD medications methylphenidate and atomoxetine. Prefrontal cortical genetic overlaps between SHR/NCrl and Wistar rats in comparison with WKY/NCrl included genes associated with transcription (e.g., Btg2, Fos, Nr4a2), synaptic plasticity (e.g., Arc, Homer2), and neuron apoptosis (Grik2, Nmnat1). Treatment with methylphenidate and/or atomoxetine increased choice of the large, delayed reward in SHR/NCrl and Wistar rats and changed, in varying degrees, mRNA levels of Nr4a2, Btg2, and Homer2, genes with previously described roles in neuropsychiatric disorders characterized by impulsivity. While further studies are required, we dissected potential genetic factors that may influence impulsivity by identifying genetic overlaps in the PFC of “impulsive” SHR/NCrl and Wistar rats. Notably, these are also drug-responsive transcripts which may be studied further as biomarkers to predict response to ADHD drugs, and as potential targets for the development of treatments to improve impulsivity.

Keywords

Impulsivity Genes SHR/NCrl Wistar rats Prefrontal cortex Methylphenidate Atomoxetine 

Notes

Funding

This work was supported by grants from the (1) Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI12C0011), (2) National Research Foundation of Korea (NRF)-2016R1D1A1B02010387, and (3) National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2015M3C7A1028926). The authors also acknowledge financial support from Loma Linda University School of Pharmacy (LLUSP-360034).

Author Contributions

I dela Peña, JH Cheong and CY Shin conceived and designed the experiments. I dela Peña, IJ dela Peña, JB de la Peña and HJ Kim performed the experiments and wrote the paper. I dela Peña, CY Shin, JH Cheong, DH Han, BN Kim and JH Ryu provided input on data analysis and interpretation. All authors reviewed the manuscript for intellectual content and approved submission.

Compliance with ethical standards

Conflict of interest

Ike dela Peña, Irene Joy dela Peña, June Bryan de la Peña, Hee Jin Kim, Chan Young Shin, Doug Hyun Han, Bung-Nyun Kim, Jong Hoon Ryu, and Jae Hoon Cheong declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. Experiments were performed in accordance with the Principles of Laboratory Animal Care (NIH Publication No. 85-23 revised 1985) and the Animal Care and Use Guidelines of Sahmyook University, South Korea. This article does not contain any studies with human participants performed by any of the authors.

References

  1. Adriani W, Laviola G (2003) Elevated levels of impulsivity and reduced place conditioning with d-amphetamine: two behavioral features of adolescence in mice. Behav Neurosci 117(4):695–703CrossRefPubMedGoogle Scholar
  2. Adriani W, Laviola G (2006) Delay aversion but preference for large and rare rewards in two choice tasks: implications for the measurement of self-control parameters. BMC Neurosci 7:52CrossRefPubMedPubMedCentralGoogle Scholar
  3. Adriani W, Caprioli A, Granstrem O, Carli M, Laviola G (2003) The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 27(7):639–651CrossRefPubMedGoogle Scholar
  4. Adriani W, Rea M, Baviera M, Invernizzi W, Carli M, Ghirardi O, Caprioli A, Laviola G (2004) Acetyl-l-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology 176(3–4):296–304CrossRefPubMedGoogle Scholar
  5. Ancín I, Cabranes JA, Vázquez-Álvarez B, Santos JL, Sánchez-Morla E, Alaerts M, Del-Favero J, Barabash A (2013) NR4A2: effects of an “orphan” receptor on sustained attention in a schizophrenic population. Schizophr Bull 39(3):555–563CrossRefPubMedGoogle Scholar
  6. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ (2008) High impulsivity predicts the switch to compulsive cocaine-taking. Science 320(5881):1352–1355CrossRefPubMedPubMedCentralGoogle Scholar
  7. Bevilacqua L, Goldman D (2013) Genetics of impulsive behavior. Philos Trans R Soc Lond B 368(1615):20120380CrossRefGoogle Scholar
  8. Bevilacqua L, Doly S, Kaprio J, Yuan Q, Tikkanen R, Paunio T, Zhou Z, Wedenoja J, Maroteaux L, Diaz S, Belmer A, Hodgkinson CA, Dell’osso L, Suvisaari J, Coccaro E, Rose RJ, Peltonen L, Virkkunen M, Goldman D (2010) A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature 468(7327):1061–1066CrossRefPubMedPubMedCentralGoogle Scholar
  9. Bezdjian S, Baker LA, Tuvblad C (2011) Genetic and environmental influences on impulsivity: a meta-analysis of twin, family and adoption studies. Clin Psychol Rev 31(7):1209–1223CrossRefPubMedPubMedCentralGoogle Scholar
  10. Bizot JC, Chenault N, Houzé B, Herpin A, David S, Pothion S, Trovero F (2007) Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats. Psychopharmacology 193(2):215–223CrossRefPubMedGoogle Scholar
  11. Botanas CJ, Lee H, de la Peña JB, Dela Peña IJ, Woo T, Kim HJ, Han DH, Kim BN, Cheong JH (2016) Rearing in an enriched environment attenuated hyperactivity and inattention in the spontaneously hypertensive rats, an animal model of attention-deficit hyperactivity disorder. Physiol Behav 155:30–37CrossRefPubMedGoogle Scholar
  12. Brakeman PR, Lanahan AA, O’Brien R, Roche K, Barnes CA, Huganir RL, Worley PF (1997) Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386(6622):284–288CrossRefPubMedGoogle Scholar
  13. Cunliffe VT (2016) The epigenetic impacts of social stress: how does social adversity become biologically embedded? Epigenomics 8(12):1653–1669CrossRefPubMedGoogle Scholar
  14. dela Peña I, Kim BN, Han DH, Kim Y, Cheong JH (2013) Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned? Arch Pharm Res 36(4):400–410CrossRefGoogle Scholar
  15. dela Peña I, Bang M, Lee J, de la Peña JB, Kim BN, Han DH, Noh M, Shin CY, Cheong JH (2015) Common prefrontal cortical gene expression profiles between adolescent SHR/NCrl and WKY/NCrl rats which showed inattention behavior. Behav Brain Res 291:268–276CrossRefPubMedGoogle Scholar
  16. Doremus-Fitzwater TL, Barreto M, Spear LP (2012) Age-related differences in impulsivity among adolescent and adult Sprague-Dawley rats. Behav Neurosci 126(5):735–741CrossRefPubMedPubMedCentralGoogle Scholar
  17. Drolet G, Proulx K, Pearson D, Rochford J, Deschepper CF (2002) Comparisons of behavioral and neurochemical characteristics between WKY, WKHA, and Wistar rat strains. Neuropsychopharmacology 27(3):400–409CrossRefPubMedGoogle Scholar
  18. Evenden JL (1999) Varieties of impulsivity. Psychopharmacology 146(4):348–361CrossRefPubMedGoogle Scholar
  19. Fan X, Bruno KJ, Hess EJ (2012) Rodent models of ADHD. Curr Top Behav Neurosci 9:273–300CrossRefPubMedGoogle Scholar
  20. Fox AT, Hand DJ, Reilly MP (2008) Impulsive choice in a rodent model of attention-deficit/hyperactivity disorder. Behav Brain Res 187(1):146–152CrossRefPubMedGoogle Scholar
  21. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D, Molina PE, Dewey SL (2000) Comparison between intraperitoneal and oral methylphenidate administration: microdialysis and locomotor activity study. J Pharmacol Exp Ther 295:51–57PubMedGoogle Scholar
  22. Gilks WP, Allott EH, Donohoe G, Cummings E, Gill M, Corvin AP, Morris DW, International Schizophrenia Consortium (2010) Replicated genetic evidence supports a role for HOMER2 in schizophrenia. Neurosci Lett 468(3):229–233CrossRefPubMedGoogle Scholar
  23. Hand DJ, Fox AT, Reilly MP (2009) Differential effects of d-amphetamine on impulsive choice in spontaneously hypertensive and Wistar-Kyoto rats. Behav Pharmacol 20(5–6):549–553CrossRefPubMedGoogle Scholar
  24. Hart AB, de Wit H, Palmer AA (2012) Genetic factors modulating the response to stimulant drugs in humans. Curr Top Behav Neurosci 12:537–577CrossRefPubMedPubMedCentralGoogle Scholar
  25. Heerey EA, Robinson BM, McMahon RP, Gold JM (2007) Delay discounting in schizophrenia. Cognit NeuroPsychiatry 12:213–221CrossRefGoogle Scholar
  26. Helms CM, Reeves JM, Mitchell SH (2006) Impact of strain and d-amphetamine on impulsivity (delay discounting) in inbred mice. Psychopharmacology 188(2):144–151CrossRefPubMedGoogle Scholar
  27. Higley JD, Thompson WW, Champoux M, Goldman D, Hasert MF, Kraemer GW, Scanlan JM, Suomi SJ, Linnoila M (1993) Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry 50(8):615–623CrossRefPubMedGoogle Scholar
  28. Ilott NE, Schneider T, Mill J, Schalkwyk L, Brolese G, Bizarro L, Stolerman IP, Dempster E, Asherson P (2014) Long-term effects of gestational nicotine exposure and food-restriction on gene expression in the striatum of adolescent rats. PLoS ONE 9(2):e88896CrossRefPubMedPubMedCentralGoogle Scholar
  29. Johansen EB, Sagvolden T, Kvande G (2005) Effects of delayed reinforcers on the behavior of an animal model of attention-deficit/hyperactivity disorder (ADHD). Behav Brain Res 162(1):47–61CrossRefPubMedGoogle Scholar
  30. Juárez J, Guerrero-Álvarez Á (2015) Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol. Behav Neurosci 129(6):756–764CrossRefPubMedGoogle Scholar
  31. Kester HM, Sevy S, Yechiam E, Burdick KE, Cervellione KL, Kumra S (2006) Decision-making impairments in adolescents with early-onset schizophrenia. Schizophr Res 85(1–3):113–123CrossRefPubMedGoogle Scholar
  32. Khadka S, Narayanan B, Meda SA, Gelernter J, Han S, Sawyer B, Aslanzadeh F, Stevens MC, Hawkins KA, Anticevic A, Potenza MN, Pearlson GD (2014) Genetic association of impulsivity in young adults: a multivariate study. Transl Psychiatry 4:e451CrossRefPubMedPubMedCentralGoogle Scholar
  33. Kim S, Lee D (2011) Prefrontal cortex and impulsive decision making. Biol Psychiatry 69(12):1140–1146CrossRefPubMedGoogle Scholar
  34. Kim P, Choi I, Pena IC, Kim HJ, Kwon KJ, Park JH, Han SH, Ryu JH, Cheong JH, Shin CY (2012) A simple behavioral paradigm to measure impulsive behavior in an animal model of attention deficit hyperactivity disorder (ADHD) of the spontaneously hypertensive rats. Biomol Ther 20(1):125–131CrossRefGoogle Scholar
  35. Kurumaji A, Nishikawa T (2012) An anxiogenic drug, FG 7142, induced an increase in mRNA of Btg2 and Adamts1 in the hippocampus of adult mice. Behav Brain Funct 8:43CrossRefPubMedPubMedCentralGoogle Scholar
  36. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O’Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lönnqvist J, Peltonen L, O’Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoëga T, Helgason T (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73(1):34–48CrossRefPubMedPubMedCentralGoogle Scholar
  37. Liu QR, Dragon T, Johnson C, Walther D, Hess J, Uhl GR (2006) Addiction molecular genetics: 639,401 SNP whole genome association identifies many “cell adhesion” genes. Am J Med Genet B 141B(8):918–925CrossRefGoogle Scholar
  38. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408CrossRefPubMedGoogle Scholar
  39. Malki K, Du Rietz E, Crusio WE, Pain O Paya-Cano J, Karadaghi RL, Sluyter F, de Boer SF, Sandnabba K, Schalkwyk LC, Asherson P, Tosto M (2016) Transcriptome analysis of genes and gene networks involved in aggressive behavior in mouse and zebrafish. Am J Med Genet B 171(6):827–838CrossRefGoogle Scholar
  40. McClure J, Podos J, Richardson HN (2014) Isolating the delay component of impulsive choice in adolescent rats. Front Integr Neurosci 8:3CrossRefPubMedPubMedCentralGoogle Scholar
  41. Myerson J, Green L, Warusawitharana M (2001) Area under the curve as a measure of discounting. J Exp Anal Behav 76(2):235–243CrossRefPubMedPubMedCentralGoogle Scholar
  42. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32(1):34–41CrossRefPubMedGoogle Scholar
  43. Odum AL (2011) Delay discounting: I’m a k, you’re a k. J Exp Anal Behav 96(3):427–439CrossRefPubMedPubMedCentralGoogle Scholar
  44. Orduña V (2015) Impulsivity and sensitivity to amount and delay of reinforcement in an animal model of ADHD. Behav Brain Res 294:62–71CrossRefPubMedGoogle Scholar
  45. Park CH, Kang JS, Shin YH, Chang MY, Chung S, Koh HC, Zhu MH, Oh SB, Lee YS, Panagiotakos G, Tabar V, Studer L, Lee SH (2006) Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons. FASEB J 20:2553–2555CrossRefPubMedGoogle Scholar
  46. Passos JA, Pires AV, Scheidt, L, de Almeida LA, Ferreira CF, Gubert C, Bizarro L, de Almeida RM (2015) Alcohol use in adolescence, impulsivity, and risk-taking behavior in Wistar rats. Psychol Neurosci 8(1):130–142CrossRefGoogle Scholar
  47. Perlmann T, Wallen-Mackenzie A (2004) Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res 318:45–52CrossRefPubMedGoogle Scholar
  48. Pfefferbaum B, Wood PB (1994) Self-report study of impulsive and delinquent behavior in college students. J Adolesc Health 15(4):295–302CrossRefPubMedGoogle Scholar
  49. Reed DD, Kaplan BA, Brewer AT (2012) A tutorial on the use of Excel 2010 and Excel for Mac 2011 for conducting delay-discounting analyses. J Appl Behav Anal 45(2):375–386CrossRefPubMedPubMedCentralGoogle Scholar
  50. Roden DM, George AL Jr (2002) The genetic basis of variability in drug responses. Nat Rev Drug Discov 1(1):37–44CrossRefPubMedGoogle Scholar
  51. Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N (2010) Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type. Neuroscience 167:1183–1191CrossRefPubMedGoogle Scholar
  52. Rojas P, Joodmardi E, Perlmann T, Ogren SO (2010) Rapid increase of Nurr1 mRNA expression in limbic and cortical brain structures related to coping with depression-like behavior in mice. J Neurosci Res 88:2284–2293CrossRefPubMedGoogle Scholar
  53. Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A (1996) Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14(4):482–486CrossRefPubMedGoogle Scholar
  54. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1239–1247CrossRefPubMedGoogle Scholar
  55. Sanabria F, Killeen PR (2008) Evidence for impulsivity in the spontaneously hypertensive rat drawn from complementary response-withholding tasks. Behav Brain Funct. 4:7CrossRefPubMedPubMedCentralGoogle Scholar
  56. Schwager AL, Haack AK, Taha SA (2014) Impaired flexibility in decision making in rats after administration of the pharmacological stressor yohimbine. Psychopharmacology 231(20):3941–3952CrossRefPubMedPubMedCentralGoogle Scholar
  57. Seroczynski AD, Bergeman CS, Coccaro EF (1999) Etiology of the impulsivity/aggression relationship: genes or environment? Psychiatry Res 86(1):41–57CrossRefPubMedGoogle Scholar
  58. Slezak JM, Anderson KG (2009) Effects of variable training, signaled and unsignaled delays, and d-amphetamine on delay-discounting functions. Behav Pharmacol 20(5–6):424–436CrossRefPubMedGoogle Scholar
  59. Slezak JM, Anderson KG (2011) Effects of acute and chronic methylphenidate on delay discounting. Pharmacol Biochem Behav 99(4):545–551CrossRefPubMedGoogle Scholar
  60. Smith KM, Bauer L, Fischer M, Barkley R, Navia BA (2005) Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder. Am J Med Genet B 133B(1):57–63CrossRefGoogle Scholar
  61. Sun H, Cocker PJ, Zeeb FD, Winstanley CA (2012) Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex. Psychopharmacology 219(2):285–301CrossRefPubMedGoogle Scholar
  62. Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M, Rohrer J, Griffin W 3rd, Toda S, Champtiaux NP, Berry T, Tu JC, Shealy SE, During MJ, Middaugh LD, Worley PF, Kalivas PW (2004) Homer proteins regulate sensitivity to cocaine. Neuron 43(3):401–413CrossRefPubMedGoogle Scholar
  63. Tirone F (2001) The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187(2):155–165CrossRefPubMedGoogle Scholar
  64. Udvardi PT, Föhr KJ, Henes C, Liebau S, Dreyhaupt J, Boeckers TM, Ludolph AG (2013) Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain—an in vivo study. Drug Des Dev Ther 7:1433–1446Google Scholar
  65. Weafer J, de Wit H (2014) Sex differences in impulsive action and impulsive choice. Addict Behav 39(11):1573–1579CrossRefPubMedGoogle Scholar
  66. Wilhelm CJ, Mitchell SH (2009) Strain differences in delay discounting using inbred rats. Genes Brain Behav 8(4):426–434CrossRefPubMedPubMedCentralGoogle Scholar
  67. Winstanley CA (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 164(4):1301–1321CrossRefPubMedPubMedCentralGoogle Scholar
  68. Winstanley CA, Eagle DM, Robbins TW (2006) Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 26(4):379–395CrossRefPubMedPubMedCentralGoogle Scholar
  69. Wooters TE, Bardo MT (2011) Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Brain Res 1396:45–53CrossRefPubMedGoogle Scholar
  70. Zeeb FD, Soko AD, Ji X, Fletcher PJ (2016) Low impulsive action, but not impulsive choice, predicts greater conditioned reinforcer salience and augmented nucleus accumbens dopamine release. Neuropsychopharmacology 41(8):2091–2100CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Ike dela Peña
    • 1
    • 2
    Email author
  • Irene Joy dela Peña
    • 2
  • June Bryan de la Peña
    • 2
  • Hee Jin Kim
    • 2
  • Chan Young Shin
    • 3
  • Doug Hyun Han
    • 4
  • Bung-Nyun Kim
    • 5
  • Jong Hoon Ryu
    • 6
    • 7
  • Jae Hoon Cheong
    • 1
    Email author
  1. 1.Department of Pharmacy, Uimyung Research Institute for NeuroscienceSahmyook UniversitySeoulRepublic of Korea
  2. 2.Department of Pharmaceutical and Administrative SciencesLoma Linda University School of PharmacyLoma LindaUSA
  3. 3.Department of Neuroscience, School of MedicineKonkuk UniversitySeoulRepublic of Korea
  4. 4.Department of PsychiatryChung-Ang University Medical SchoolSeoulRepublic of Korea
  5. 5.Division of Child and Adolescent Psychiatry, Department of PsychiatrySeoul National University College of MedicineSeoulRepublic of Korea
  6. 6.Department of Life and Nanopharmaceutical ScienceCollege of Pharmacy, Kyung Hee UniversitySeoulRepublic of Korea
  7. 7.Department of Oriental Pharmaceutical ScienceCollege of Pharmacy, Kyung Hee UniversitySeoulRepublic of Korea

Personalised recommendations